Skip to main content

Advertisement

SpringerLink
Log in

Rabies

  • Published:
Current Treatment Options in Neurology Aims and scope Submit manuscript

Opinion statement

Human rabies is fatal except in the small number of patients who received rabies immunization before the onset of clinical rabies. Therapy has been futile in all other cases once rabies has developed. Rabies is always preventable after an exposure if current recommendations are followed. After a potential rabies exposure, details about the contact, the animal, and the local epidemiologic situation are important in making a decision whether to initiate postexposure prophylaxis (PEP). Rabies PEP includes thorough local wound cleansing and both active and passive immunization. Five doses of rabies vaccine should be administered intramuscularly in the deltoid muscle on days 0, 3, 7, 14, and 28 in individuals previously unimmunized against rabies virus. Human rabies immune globulin (20 IU/kg) should be given on day 0 with administration into and around the wounds; the remaining volume is given intramuscularly at a site distant from the vaccine site. Certain individuals at high risk for rabies exposure are candidates for preexposure prophylaxis with three doses of rabies vaccine. Booster doses should be given as required.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Steele JH, Fernandez PJ: History of rabies and global aspects. In The Natural History of Rabies, edn 2. Edited by Baer GM. Boca Raton, FL: CRC Press; 1991:1–24.

    Google Scholar 

  2. Noah DL, Drenzek CL, Smith JS, et al.: Epidemiology of human rabies in the United States, 1980 to 1996. Ann Intern Med 1998, 128:922–930. Excellent retrospective review of all known cases of human rabies in the United States between 1980 and 1996, including clinical and laboratory information.

    PubMed  CAS  Google Scholar 

  3. Jackson AC:Rabies. In Viral Pathogenesis. Edited by Nathanson N, Ahmed R, Gonzalez-Scarano F, et al. Philadelphia: Lippincott-Raven; 1997:575–591. Good comprehensive review of the pathogenesis of rabies with information from important experimental studies in animals.

    Google Scholar 

  4. Charlton KM, Nadin-Davis S, Casey GA, Wandeler AI: The long incubation period in rabies: delayed progression of infection in muscle at the site of exposure. Acta Neuropathol 1997, 94:73–77.

    Article  PubMed  CAS  Google Scholar 

  5. Lentz TL, Burrage TG, Smith AL, et al.: Is the acetylcholine receptor a rabies virus receptor? Science 1982, 215:182–184.

    Article  PubMed  CAS  Google Scholar 

  6. Tsiang H, Ceccaldi PE, Lycke E: Rabies virus infection and transport in human sensory dorsal root ganglia neurons. J Gen Virol 1991, 72:1191–1194.

    Article  PubMed  Google Scholar 

  7. Hattwick MAW, Weis TT, Stechschulte CJ, et al.: Recovery from rabies: a case report. Ann Intern Med 1972, 76:931–942.

    PubMed  CAS  Google Scholar 

  8. Porras C, Barboza JJ, Fuenzalida E, et al.: Recovery from rabies in man. Ann Intern Med 1976, 85:44–48.

    PubMed  CAS  Google Scholar 

  9. Tillotson JR, Axelrod D, Lyman DO: Rabies in a laboratory worker—New York. MMWR 1977, 26:183–184.

    Google Scholar 

  10. Tillotson JR, Axelrod D, Lyman DO: Follow-up on rabies—New York. MMWR 1977, 26:249–250.

    Google Scholar 

  11. Alvarez L, Fajardo R, Lopez E, et al.: Partial recovery from rabies in a nine-year-old boy. Pediatr Infect Dis J 1994, 13:1154–1155.

    Article  PubMed  CAS  Google Scholar 

  12. Merigan TC, Baer GM, Winkler WG, et al.: Human leukocyte interferon administration to patients with symptomatic and suspected rabies. Ann Neurol 1984, 16:82–87.

    Article  PubMed  CAS  Google Scholar 

  13. Warrell MJ, White NJ, Looareesuwan S, et al.: Failure of interferon alfa and tribavirin in rabies encephalitis. Br Med J 1989, 299:830–833.

    Article  CAS  Google Scholar 

  14. Emmons RW, Leonard LL, DeGenaro F, et al.: A case of human rabies with prolonged survival. Intervirology 1973, 1:60–72.

    PubMed  CAS  Google Scholar 

  15. Hattwick MA, Corey L, Creech WB: Clinical use of human globulin immune to rabies virus. J Infect Dis 1976, 133(suppl):A266-A272.

    PubMed  Google Scholar 

  16. Basgoz N, Frosch MP: Case records of the Massachusetts General Hospital: a 32-year-old woman with pharyngeal spasms and paresthesias after a dog bite. N Engl J Med 1998, 339:105–112.

    Article  Google Scholar 

  17. Shill M, Baynes RD, Miller SD: Fatal rabies encephalitis despite appropriate post-exposure prophylaxis. N Engl J Med 1987, 316:1257–1258.

    Article  PubMed  CAS  Google Scholar 

  18. Wilde H, Sirikawin S, Sabcharoen A, et al.: Failure of postexposure treatment of rabies in children. Clin Infect Dis 1996, 22:228–232.

    PubMed  CAS  Google Scholar 

  19. Centers for Disease Control and Prevention: Human rabies prevention—United States, 1999: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1999, 48(No._RR-1):1–21. Current United States guidelines for the prevention of rabies in humans.

    Google Scholar 

  20. Meslin F-X, Kaplan MM, Koprowski H, eds: Laboratory Techniques in Rabies, edn 4. Geneva: World Health Organization; 1996.

    Google Scholar 

  21. Hanlon CA, Olson JG, Clark CJ: Article I: Prevention and education regarding rabies in human beings. National Working Group on Rabies Prevention and Control. J Am Vet Med Assoc 1999, 215:1276–1280.

    PubMed  CAS  Google Scholar 

  22. Schnurrenberger P, Dreesen D, Brown J, et al.: Systemic allergic reactions following immunization with human diploid cell rabies vaccine. MMWR 1984, 33:185–187.

    Google Scholar 

  23. Fishbein DB, Yenne KM, Dreesen DW, et al.: Risk factors for systemic hypersensitivity reactions after booster vaccinations with human diploid cell rabies vaccine: a nationwide prospective study. Vaccine 1993, 11:1390–1394.

    Article  PubMed  CAS  Google Scholar 

  24. Anderson LJ, Winkler WG, Hafkin B, et al.: Clinical experience with a human diploid cell rabies vaccine. JAMA 1980, 244:781–784.

    Article  PubMed  CAS  Google Scholar 

  25. Bahmanyar M, Fayaz A, Nour-Salehi S, et al.: Successful protection of humans exposed to rabies infection. Postexposure treatment with the new human diploid cell rabies vaccine and antirabies serum. JAMA 1976, 236:2751–2754.

    Article  PubMed  CAS  Google Scholar 

  26. Anderson LJ, Sikes RK, Langkop CW, et al.: Postexposure trial of a human diploid cell strain rabies vaccine. J Infect Dis 1980, 142:133–138.

    PubMed  CAS  Google Scholar 

  27. Baltazard M, Bahmanyar M, Ghodssi M, et al.: Essai pratique du sérum antirabique chez les mordus par loups enragés. Bull WHO 1955, 13:747–772.

    PubMed  CAS  Google Scholar 

  28. Selimov M, Boltucij L, Semenova E, et al.: Anwendung des Anti-rabies Gama-globulins bei Menschen, die von tollwutigen Wolfen oder anderen Tieren schwer gebissen wurden. J Hyg Epidemiol Microbiol Immunol 1959, 3:168–180.

    PubMed  CAS  Google Scholar 

  29. Kaplan MM, Cohen D, Koprowski H, et al.: Studies on the local treatment of wounds for the prevention of rabies. Bull WHO 1962, 26:765–775.

    PubMed  CAS  Google Scholar 

  30. Dean DJ, Baer GM, Thompson WR: Studies on the local treatment of rabies-infected wounds. Bull WHO 1963, 28:477–486.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Medicine and of Microbiology and Immunology, Queen’s University, Kingston General Hospital, Connell 725, 76 Stuart Street, K7L 2V7, Kingston, ON, Canada

    Alan C. Jackson MD

Authors
  1. Alan C. Jackson MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jackson, A.C. Rabies. Curr Treat Options Neurol 2, 369–373 (2000). https://doi.org/10.1007/s11940-000-0054-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11940-000-0054-6

Keywords

Search

Navigation